Bergamot polyphenol fraction (BPF) is one of the most studied plant extracts for cholesterol management. Randomised trials show LDL reduction of 20-35%, comparable to low-dose statin. Italy has 10+ RCTs published.
How it works (mechanism of action)
Brutieridin and melitidin inhibit HMG-CoA reductase (same mechanism as statins). Naringenin activates AMPK. Neohesperidin improves endothelial function. Reduces PCSK9 expression increasing LDL receptor activity.
Evidence grades: A=Strong RCT evidence · B=Good clinical trials · C=Limited trials · D=Preliminary/traditional
Generally safe. May lower blood sugar — monitor in diabetics. Potential statin interaction (additive). Bergapten content — photosensitising with topical application (not relevant for oral supplement). No serious safety concerns at studied doses.
